Citizens JMP Reiterates a Buy Rating on Sana Biotechnology (SANA) With a $5 PT
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the top strong buy stocks under $5 to buy now.
Sana Biotechnology Inc. (SANA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 2,955,047 | $8,067,278 | -14% | 0% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,030,949 | $5,544,491 | 0.05% | |
| 3. | Integral Health Asset Management Bhagwan Jay Rao | 1,500,000 | $4,095,000 | -25% | 0.37% |
| 4. | AQR Capital Management Cliff Asness | 1,356,363 | $3,702,871 | +137% | 0% |
| 5. | Millennium Management Israel Englander | 797,577 | $2,177,385 | +237% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 363,637 | $2,000,003.50 | 10,667,387 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.26 | 1,000 | $7,260.00 | 4,541,511 | 2025-01-08 | Filing | |
| $6.71 | 164,912 | $1,106,559.52 | 4,542,511 | 2025-01-08 | Filing | |
| $6.50 | 25,000 | $162,500.00 | 4,707,423 | 2025-01-08 | Filing | |
| $6.11 | 100,000 | $611,000.00 | 4,732,423 | 2025-01-08 | Filing | |
| $3.89 | 150,000 | $583,170.00 | 2,698,121 | 2024-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 33,833,306 | $92,364,925 | 0.01% | |
| 2. | 25,001,856 | $68,255,067 | 25.42% | |
| 3. | 10,858,900 | $29,644,798 | 0% | |
| 4. | 10,175,000 | $27,777,750 | 0.02% | |
| 5. | 10,064,728 | $27,476,706 | 0.02% |
News See All
15 Strong Buy Stocks Under $5 to Buy Now
On August 22, Tom Lee, head of research and chief investment officer of Fundstrat Capital, appeared on CNBC’s ‘Squawk on the Street’ to talk about what he thinks about Fed Chair Powell’s speech...
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the penny stocks that will skyrocket.
Citi Remains Bullish on Sana Biotechnology (SANA)
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best biotech penny stocks to buy right now. Citi analyst Samantha Semenkow maintained a bullish stance on Sana Biotechnology, Inc.
14 Best Biotech Penny Stocks to Buy Right Now
He acknowledged that biotech has been a “super tough sector” either way, as there are hundreds of publicly traded stocks that do not add up to anything in aggregate.
10 Penny Stocks That Will Skyrocket
Valuations in the equity markets sit at historical highs, raising questions about future market performance.
11 Best American Penny Stocks to Buy According to Analysts
On July 19, Bailard released its Q2 2025 Small Cap Value Strategy report. The report highlights that in early April, fears of trade wars pushed the US equity markets near bear market territory.
Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley
Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has assumed coverage on Sana Biotechnology, Inc.
12 Best Fundamentally Strong Penny Stocks to Invest in
We have all heard the old saying, “A penny makes a dime,” highlighting the idea that every little effort counts toward a bigger goal.